Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice

Journal of Cellular Physiology

Volumn 218, Issue 2, 2009, Pages 276-284

  Macrae, V E ^a   Horvat, S ^b   Pells, S C ^a   Dale, H ^c   Collinson, R S ^c   Pitsillides, A A ^c   Ahmed, S F ^d   Farquharson, C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SUPPRESSOR OF CYTOKINE SIGNALING 2; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; MESSENGER RNA; SOCS2 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE GROWTH; BONE MASS; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FEMALE; GROWTH PLATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TRABECULAR BONE; ANIMAL; BONE DEVELOPMENT; CARTILAGE CELL; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; METATARSAL BONE; NEWBORN; ORGAN SIZE; OSTEOLYSIS; TIBIA;

MUS;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; BONE DEVELOPMENT; BONE RESORPTION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GROWTH PLATE; INFLAMMATION MEDIATORS; METATARSAL BONES; MICE; ORGAN SIZE; OSTEOGENESIS; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIBIA;

EID: 58149218915     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21593     Document Type: Article

References (47)

1. Andreassen TT, Oxlund H. 2001. The effects of growth hormone on cortical and cancellous bone. J Musculoskelet Neuronal Interact 2:49-58.
2. Atsumi T, Miwa Y, Kimata K, Ikawa Y. 1990. A chondrogenic cell-line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev 30:109-116.
3. Bradley A. 1987. Production and analysis of chimaeric mice. In: Robertson EJ, editor. Teratocarcinomas and embryonic stem cells: A practical approach. USA: Oxford University Press. pp. 113-151.
4. Dey BR, Spence SL, Nissley P, Furlanetto RW. 1998. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J Biol Chem 273:24095-24101.
5. Dogusan Z, Hooghe-Peters EL, Berus D, Velkeniers B, Hooghe R. 2000. Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines. J Neuroimmunol 109:34-39.
6. Farquharson C, Lester D, Seawright E, Jefferies D, Houston B. 1999. Microtubules are potential regulators of growth-plate chondrocyte differentiation and hypertrophy. Bone 25:405-412.
7. Goldshmit Y, Walters CE, Scott HJ, Greenhalgh CJ, Turnley AM. 2004. SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation. J Biol Chem 279:16349-16355.
8. Greenhalgh CJ, Bertolino P, Asa SL, Metcalf D, Corbin JE, Adams TE, Davey HW, Nicola NA, Hilton DJ, Alexander WS. 2002. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol Endocrinol 16:1394-1406.
9. Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA, Nash AD, Fabri LJ, Norstedt G, Ohlsson C, Flores-Morales A, Alexander WS, Hilton DJ. 2005. SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 115:397-406.
10. Hildebrand T, Ruegsegger P. 1997. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Eng 1:15-23.
11. Horvat S, Medrano JF. 1998. A 500-kb YAC and BAC contig encompassing the high-growth deletion in mouse chromosome 10 and identification of the murine Raidd/Cradd gene in the candidate region. Genomics 54:159-164.
12. Horvat S, Medrano JF. 2001. Lack of Socs2 expression causes the high-growth phenotype in mice. Genomics 72:209-212.
13. Houston B, Seawright E, Jefferies D, Hoogland E, Lester D, Whitehead C, Farquharson C. 1999. Identification and cloning of a novel phosphatase expressed at high levels in differentiating growth plate chondrocytes. BBA-Mol Cell Res 1448:500-506.
14. Kasukawa Y, Miyakoshi N, Mohan S. 2004. The anabolic effects of GH/IGF system on bone. Curr Pharm Des 10:2577-25792.
15. Krebs DL, Hilton DJ. 2001. SOCS proteins: Negative regulators of cytokine signaling. Stem Cells 19:378-387.
16. Lefebvre V, Garofalo S, Zhou G, Metsäranta M, Vuorio E, De Crombrugghe B. 1994. Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol 14:329-335.
17. Leroith D, Nissley P. Knock your SOCS, off. J Clin Invest 115:233-236. 2005.
18. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
19. Lorentzon M, Greenhalgh CJ, Mohan S, Alexander WS, Ohlsson C. 2005. Reduced bone mineral density in SOCS-2-deficient mice. Pediatr Res 57:223-226.
20. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. 2001. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162.
21. MacRae VE, Wong SC, Farquharson C, Ahmed SF. 2006a. Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases. Int J Mol Med 18:1011-1018.
22. MacRae VE, Farquharson C, Ahmed SF. 2006b. The pathophysiology of the growth plate in juvenile idiopathic arthritis. Rheumatology 45:11-19.
23. MacRae VE, Farquharson C, Ahmed SF. 2006c. The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to proinflammatory cytokines. J Endocrinol 189:319-328.
24. MacRae VE, Burdon T, Ahmed SF, Farquharson C. 2006d. Ceramide inhibition of chondrocyte proliferation and bone growth is IGF-I independent. J Endocrinol 191:369-377.
25. MacRae VE, Wong SC, Smith W, Gracie A, McInnes I, Galea P, Gardner-Medwin J, Farquharson C, Ahmed SF. 2007. Cytokine profiling and in vitro studies of murine bone growth using biological fluids from children with juvenile idiopathic arthritis. Clin Endocrinol 67:442-448.
26. Magin TM, McWhir J, Melton DW. 1992. A new mouse embryonic stem-cell line with good germ line contribution and gene targeting frequency. Nucleic Acids Res 20:3795-3795.
27. Martensson K, Chrysis D, Savendahl L. 2004. Interleukin-1 beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 19:1805-1812.
28. Medrano JF, Pomp D, Sharrow L, Bradford GE, Downs TR, Frohman LA. 1991. Growth hormone and insulin like growth factor-I measurements in high growth (hg) mice. Genet Res 58:67-74.
29. Metcalf D, Greenhalgh CJ, Viney E, Wilson TA, Starr R, Nicola NA, Hilton DJ, Alexander WS. 2000. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405:1069-1073.
30. Mountford P, Zevnik B, Duwel A, Nichos J, Li M, Dani C, Robertson M, Chambers I, Smith A. 1994. Dicistronic targeting constructs: Reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci USA 91:4303-4307.
31. Mushtaq T, Farquharson C, Seawright E, Ahmed SF. 2002. Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line. J Endocrinol 175:705-713.
32. Mushtaq T, Bijman P, Ahmed SF, Farquharson C. 2004. Insulin-like growth factor-I augments chondrocyte hypertrophy and reverses glucocorticoid-mediated growth retardation in fetal mice metatarsal cultures. Endocrinology 145:2478-2486.
33. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. 1998. Growth hormone and bone. Endocr Rev 19:55-79.
34. Ouyang X, Fujimoto M, Nakagawa R, Serada S, Tanaka T, Nomura S, Kawase I, Kishimoto T, Naka T. 2006. SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells. J Cell Physiol 207:428-436.
35. Powell-Braxton L, Hollingshead P, Giltinan D, Pitts-Meek S, Stewart T. 1993. Inactivation of the IGF-I gene in mice results in perinatal lethality. Ann NY Acad Sci 692:300-301.
36. Ram PA, Waxman DJ. 1999. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274:35553-35561.
37. Rico-Bautista E, Flores-Morales A, Fernandez-Perez L. 2006. Suppressor of cytokine signalling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev 17:431-439.
38. Santangelo C, Scipioni A, Marselli L, Marchetti P, Dotta F. 2005. Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. Eur J Endocrinol 152:485-489.
39. Shen X, Hong F, Nguyen VA, Gao B. 2000. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3. FEBS Lett 480:132-136.
40. Sjögren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, Leroith D, Jan Törnell J, Isaksson OGP, Jansson JO, Ohlsson C. 1999. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088-7092.
41. Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C. 1996. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3 and 5 by GH. Mol Endocrinol 10:519-533.
42. Uyttendaele I, Lemmens I, Verhee A, De Smet AS, Vandekerckhove J, Lavens D, Peelman F, Tavernier J. 2007. Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor. Mol Endocrinol 21:2821-2831.
43. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA. 2004a. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 180:247-255.
44. Wang L, Zhang Z, Zhang R, Hafner MS, Wong HK, Jiao Z, Chopp M. 2004b. Erythropoietin up-regulates SOCS2 in neuronal progenitor cells derived from SVZ of adult rat. Neuroreport 15:1225-1229.
45. Yakar S, Liu JLI, Stannard B, Butler A, Accili D, Sauer B, Leroith D. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329.
46. Yoshimura A, Naka T, Kubo M. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7:454-465.
47. Zong CS, Chan J, Levy DE, Horvath C, Sadowski HB, Wang L. 2000. Mechanism of STAT3 activation by insulin-like growth factor I receptor. J Biol Chem 275:15099-15105.